StonvexLoading…
StonvexStonvexStonvexCore line items from AKA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $132.46M | $600.21M | $436.26M | $289.18M |
Operating Income | $-4.10M | $-18.05M | $-7.30M | $-5.87M |
Net Income | $-7.13M | $-31.43M | $-16.93M | $-11.97M |
EPS (Diluted) | $-0.66 | $-2.93 | $-1.58 | $-1.13 |
Total Assets | $397.69M | $397.38M | $411.33M | $410.82M |
Total Liabilities | $303.27M | $299.61M | $301.22M | $296.68M |
Cash & Equivalents | $12.86M | $20.27M | $23.43M | $23.11M |
Free Cash Flow OCF − CapEx | $-6.41M | $-633.00K | $2.41M | $2.09M |
Shares Outstanding | 10.82M | 10.77M | 10.71M | 10.75M |